Ergebnisse einschränken

Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD)

Pfeil, A. ; Imfeld, P. ; Pettengell, R. ; Jick, S. ; Szucs, T. ; Meier, Christoph ; Schwenkglenks, M.

In: Annals of Hematology, 2015, vol. 94, no. 3, p. 421-429

Prospective Survey of AntibioticUtilization in Pediatric Hospitalized Patients to IdentifyTargets for Improvement of Prescription

Potocki, M. ; Goette, J. ; Szucs, T. ; Nadal, D.

In: Infection, 2003, vol. 31, no. 6, p. 398-403

Disparities in influenza vaccination coverage rates by target group in five European countries: Trends over seven consecutive seasons

Blank, P. ; Schwenkglenks, M. ; Szucs, T.

In: Infection, 2009, vol. 37, no. 5, p. 390-400

Medizinische Ökonomie in der Onkologie : Eine Einführung = Medical economics in oncology : An introduction

Szucs, T.

Influenza Vaccination Coverage Rates in 5 European Countries: a Population-Based Cross-Sectional Analysis of the Seasons 02/03, 03/04 and 04/05

Müller, D. ; Szucs, T.

In: Infection, 2007, vol. 35, no. 5, p. 308-319

Personalized cancer medicine and the future of pathology

Moch, H. ; Blank, P. ; Dietel, M. ; Elmberger, G. ; Kerr, K. ; Palacios, J. ; Penault-Llorca, F. ; Rossi, G. ; Szucs, T.

In: Virchows Archiv, 2012, vol. 460, no. 1, p. 3-8

Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis

Joerger, M. ; Matter-Walstra, K. ; Früh, M. ; Kühnel, U. ; Szucs, T. ; Pestalozzi, B. ; Schwenkglenks, M.

In: Annals of Oncology, 2011, vol. 22, no. 3, p. 567-574